Evidence That the Immunosuppressive Effects of Antithyroid Drugs Are Mediated through Actions on the Thyroid Cell, Modulating Thyrocyte-Immunocyte Signaling: A Review (Q40392930)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 1, 1994

Language	Label	Description	Also known as
English	Evidence That the Immunosuppressive Effects of Antithyroid Drugs Are Mediated through Actions on the Thyroid Cell, Modulating Thyrocyte-Immunocyte Signaling: A Review	scientific article published on January 1, 1994

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1 reference

Europe PubMed Central

Evidence that the immunosuppressive effects of antithyroid drugs are mediated through actions on the thyroid cell, modulating thyrocyte-immunocyte signaling: a review (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Evidence That the Immunosuppressive Effects of Antithyroid Drugs Are Mediated through Actions on the Thyroid Cell, Modulating Thyrocyte-Immunocyte Signaling: A Review (English)

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

author name string

R. Volpé

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7522684

16 May 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7522684

16 May 2024

publication date

1 January 1994

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

full work available at URL

https://www.liebertpub.com/doi/pdf/10.1089/thy.1994.4.217

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

217-223

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Autoimmune Thyroid Disease: Developments in Our Understanding

1

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

Carbimazole and the Autoimmune Response in Graves' Disease

2

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

Specificity of the immunosuppressive action of carbimazole in Graves's disease

3

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

Inhibition of Immunoglobulin-Secreting Cells by Antithyroid Drugs*

4

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

Evidence that antithyroid drugs induce remissions in Graves' disease by modulating thyroid cellular activity

5

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

Immunoregulation in autoimmune thyroid disease

7

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies

8

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

Thyroid stimulating antibodies (TSAb) in patients with Graves' disease undergoing antithyroid drug treatment: indicators of activity of disease

10

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

Changes of circulating thyroid autoantibody levels during and after the therapy with methimazole in patients with Graves' disease

11

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

The influence of preoperative drug treatment on the histological appearances and in vitro 131I uptake of human hyperplastic thyroid gland

14

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

The influence of methimazole on thyroglobulin-induced autoimmune thyroiditis in the rat

17

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

The Effect of Methimazole on the Development of Spontaneous Lymphocytic Thyroiditis in the Diabetes-Prone BB/W Rat

18

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

Uptake and metabolism of iodine is crucial for the development of thyroiditis in obese strain chickens

19

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

Influence of methimazole on murine thyroiditis. Evidence for immunosuppression in vivo

20

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

The effect of carbimazole on thyroid autoantibody synthesis by thyroid lymphocytes

21

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

Methimazole and generation of oxygen radicals by monocytes: potential role in immunosuppression.

23

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

Comparison of Effects of High and Low Dosage Regimens of Antithyroid Drugs in the Management of Graves’ Hyperthyroidism*

24

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

Carbimazole and autoantibody synthesis in Hashimoto's thyroiditis

26

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

Methimazole, but not betamethasone, prevents 131I treatment-induced rises in thyrotropin receptor autoantibodies in hyperthyroid Graves' disease

28

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

Intrathyroidal concentrations of methimazole in patients with Graves' disease

29

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

The acclumulation of 35 S-antithyroid drugs by the thyroid gland.

30

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease

32

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

Activated (Ia+) T-lymphocytes and their subsets in autoimmune thyroid diseases: analysis by dual laser flow microfluorocytometry

33

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

Suppression of peripheral blood natural killer cell activity by excess thyroid hormone

34

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

Thyroid function and thyroid autoimmunity independently modulate serum concentration of soluble interleukin 2 (IL-2) receptor (sIL-2R) in thyroid diseases

36

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

High levels of serum soluble interleukin-2 receptors in hyperthyroid patients: correlation with serum thyroid hormones and independence from the etiology of the hyperthyroidism

37

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

Studies of CD4+ (Helper/Inducer) T Lymphocytes in Autoimmune Thyroid Disease: Demonstration of Specific Induction in Response to Thyroid Peroxidase (TPO) In Vitro and Its Relationship with Thyroid Status In Vivo

38

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

The effects of hyperthyroidism on experimental autoimmune thyroiditis in the rat

40

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

Immunological features of nonimmunogenic hyperthyroidism

41

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

SERUM SOLUBLE INTERLEUKIN 2 RECEPTOR IN HYPERTHYROID Graves'DISEASE AND EFFECT OF CARBIMAZOLE THERAPY

43

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

Soluble interleukin-2 receptor in sera of patients with Graves' disease

44

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

The effect of methimazole on the immune system is unlikely to operate directly on T lymphocytes

45

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

Effects of antithyroid drugs on lymphocyte function in vitro

46

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

Effect of the anti-thyroid drug methimazole on interleukin-1 and interleukin-2 levels in vitro

47

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

Studies of HLA-DR expression on cultured human thyrocytes: effect of antithyroid drugs and other agents on interferon-gamma-induced HLA-DR expression

48

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

Lack of effect of methimazole on thyrocyte cell-surface antigen expression

49

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

The influence of antithyroid drugs and iodine on thyroid cell MHC class II antigen expression

51

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

Antithyroid drugs and release of inflammatory mediators by complement-attacked thyroid cells

53

1 reference

10.1089/THY.1994.4.217

https://api.crossref.org/works/10.1089/THY.1994.4.217

16 May 2024

Identifiers

10.1089/THY.1994.4.217

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40392930&oldid=2155507864"